[Cellular targets of antitumor ribonucleases]
Molekuliarnaia Biologiia
|April 9, 2015
Summary
Ribonucleases (RNases) show selective toxicity to cancer cells by interacting with cellular components to induce apoptosis. Understanding these mechanisms could lead to new targeted anticancer therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Ribonucleases (RNases) exhibit selective toxicity towards cancer cells.
- The precise mechanisms underlying this antitumor activity are not fully understood.
Purpose of the Study:
- To review the interactions between exogenous RNases and cellular components that lead to tumor cell apoptosis.
- To explore potential intracellular targets and signaling pathways involved in RNase-induced cancer cell death.
Main Methods:
- Review of existing literature on RNase-cancer cell interactions.
- Analysis of cell surface structures as potential RNase acceptors.
- Examination of intracellular RNA targets and RNA interference pathways.
- Discussion of signaling pathways (e.g., NF-kappaB) and caspases in apoptosis.
Main Results:
- Cell surface differences between normal and malignant cells influence RNase selectivity.
- Exogenous RNases can potentially interfere with RNA interference.
- RNase-induced apoptosis involves potassium channels, NF-kappaB signaling, and caspases.
- Sensitivity to RNases correlates with oncogene expression (RAS, KIT, AML1-ETO).
Conclusions:
- RNase interactions with cellular components trigger apoptosis in susceptible cancer cells.
- Understanding these mechanisms is crucial for developing novel targeted anticancer therapies.
More Related Videos
12:28Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
Published on: January 11, 2019
7.9K
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
2.3K
Related Concept Videos
Targeted Cancer Therapies
9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.2K
Targeted Cancer Therapies
1.8K
1.8K
Ribozymes
13.8K
The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can...
Ribozymes can...
13.8K
Ribozymes
3.9K
3.9K
Types of RNA
74.2K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
74.2K
The Nucleolus
10.8K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
10.8K
